Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase I/II trial of autologous bone marrow stem cells in amyotrophic lateral sclerosis
2006-003096-12Phase 2Completed
- Sponsor
- Fundación para la Formación e Investigación Sanitaria
- Start
- Mar 2010
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of autologous bone marrow-derived mononuclear cell in amyotrophic lateral sclerosis (ALS), sponsored by Fundación para la Formación e Investigación Sanitaria. Primary endpoints: Neurological evaluation, Neurophysiological evaluation and 3 more. Started Mar 2010; status: completed.
02
Drugs
autologous bone marrow-derived mononuclear cell
03
Conditions
amyotrophic lateral sclerosis (ALS)
Beyond the preview
Go deeper on 2006-003096-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-003096-12.